LONG-TERM FOLLOW-UP OF THE NEXT GENERATION PI3K-DELTA INHIBITOR TGR-1202 DEMONSTRATES SAFETY AND HIGH RESPONSE RATES IN CLL: INTEGRATED-ANALYSIS OF TGR-1202 MONOTHERAPY AND COMBINED WITH UBLITUXIMAB

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Mato, A; Burris, HA; Flinn, I; Lunning, M; Vose, J; Fowler, N; Nastoupil, L; O'Brien, S; Schreeder, MT; Patel, MR; Fenske, TS; Brander, DM; Siddiqi, T; Flowers, C; Burger, JA; Wierda, WG; Kuhn, JG; Sportelli, P; Miskin, H; Weiss, MS; O'Connor, OA

Published Date

  • June 1, 2016

Published In

Volume / Issue

  • 101 /

Start / End Page

  • 50 - 51

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0390-6078

Conference Name

  • 21st Congress of the European-Hematology-Association

Conference Location

  • Copenhagen, DENMARK

Conference Start Date

  • June 9, 2016

Conference End Date

  • June 12, 2016